Healthy aging made possible

Founded on the belief that every person has the right to live a longer, healthier life, Hevolution Foundation is a global catalyst, partner, and convener on a mission to drive efforts to extend healthy human lifespan and understand the processes of aging. With a focus on aging as a treatable process, Hevolution Foundation aims to increase the number of aging-related treatments on the market, compress the timeline of drug development, and increase accessibility to therapeutics that extend healthy lifespan, also known as healthspan. A global non-profit organization headquartered in Riyadh with a North American hub and an annual budget of up to $1 billion, Hevolution Foundation plans to open offices in other global locations to support a cutting-edge, global ecosystem of talent to propel aging and geroscience research forward and achieve medical breakthroughs to help humanity live healthier, longer.

SOLVE FSHD is a venture philanthropic organization established to catalyze innovation and accelerate key research in finding a cure for FSHD, established by renowned Canadian entrepreneur and philanthropist, Chip Wilson. The Wilson family has committed $100 million to kick-start funding into projects that support the organization’s mission to find a cure for FSHD by 2027. The goal of SOLVE FSHD is to find a solution that can slow down or stop muscle degeneration, increase muscle regeneration and strength, and improve the quality of life for those living with FSHD. 

Named by Fortune as one of the “World’s 50 Greatest Leaders,” Peter Diamandis is the Founder and Executive Chairman of the XPRIZE Foundation, which leads the world in designing and operating large-scale incentive competitions. He is also the Executive Founder of Singularity University.

As an entrepreneur, Diamandis has started over 25 companies in the areas of health-tech, space, venture capital and education. He is Co-founder and Vice-Chairman of two public companies, Celularity and Vaxxinity. Dr. Diamandis is Co-founder & Chairman of Fountain Life, a fully-integrated platform delivering predictive, preventative, personalized and data-driven health. Finally, he also serves as Co-founder of BOLD Capital Partners, a venture fund with a half-billion dollars under management being invested in exponential technologies and longevity companies. 

Diamandis is a New York Times Bestselling author of four books: Abundance – The Future Is Better Than You Think, BOLD – How to go Big, Create Wealth & Impact the World and The Future is Faster Than You Think. Most recently he co-Authored the #1 best seller LIFE FORCE with Tony Robbins which chronicles the extraordinary healthcare and biotech revolution unfolding before our eyes. 

He earned degrees in molecular genetics and aerospace engineering from MIT and holds an M.D. from Harvard Medical School. Diamandis’ favorite saying is “The best way to predict the future is to create it yourself.

In the mid-1980s, Carl began building a network of private colleges, and over the course of two decades, built 20 on-ground campuses and Independence University. He ran a successful group of quality private colleges and was a leader in the post-secondary private college sector. The colleges exclusively offered degree programs up to Masters levels in healthcare (respiratory therapy, nursing, etc.), business and accounting, graphic arts, and computer science.

Carl discovered Ayn Rand’s philosophy in 1980. He has used the principles of Rand’s philosophy, Objectivism, to guide my life and business ventures, and I have been successful and created wealth. Now, he wants to advance her ideas so that other people will discover and benefit from them too. Several years ago, Carl created the Prometheus Foundation for the purpose of providing seed money for those who want to advance Ayn Rand and Objectivism.

Over the years, he has served on many boards, including the Ayn Rand Institute, the Cato Institute, and the Clemson Institute for the Study of Capitalism.

Brett Blundy stands as the visionary Chairman, 100% owner, and Founder of BB Retail Capital (BBRC), a private investment firm with an illustrious 40+ year legacy of skillfully establishing, nurturing, and investing in businesses. His entrepreneurial journey commenced over four decades ago with his first business, a single retail record store. Since then, his unwavering dedication to operational excellence and investing has propelled him to manage a global business and investment portfolio. Some of the brands that BBRC owns include Scooter Hut, Best & Less, and Postie. BBRC also has strong investment partnerships with Bared, Hot 8 Yoga, Pioneer, Plant Therapy, and Psycho Bunny. Brett is actively involved in all aspects of BBRC, and he is also the Chairman and Founder of Lovisa (ASX: LOV), a board member, and a significant shareholder in Accent Group (ASX: AX1).

Additionally, BBRC proudly owns and manages an expansive 5 million acres of land in Australia's Northern Territory, where it oversees a thriving cattle operation with over 133,000 head. The firm has offices in three continents: Australia, Singapore, and Monaco. Brett’s unwavering pursuit of excellence and his dedication to investing in promising ventures have solidified his position as a respected leader in the business world. 

Brett is a member of YPO and XPRIZE, organizations that champion innovation and entrepreneurship. A lifelong learner, he passionately advocates for proactive treatment and prevention strategies to combat chronic age-related diseases.

Kas Bordier stands at the intersection of finance and biotech, and is a driving force behind healthspan technologies as investor and entrepreneur. Her journey, from the stark post-iron curtain Poland to the innovation centers of London and Singapore, reflects her commitment to turning the promise of extended vitality into reality. With a keen insight derived from her transcontinental experience, she stands at the vanguard of healthtech, investing in solutions that bring quality healthspan within everyone's reach.

Charlie and Lorie Epstein have been committed to supporting organizations that are dedicated to making a “dent-in-the-universe.” They believe a life worth living is a life worth giving. To that end, they have supported organizations like HeartWorks, which uses advanced stem cell technology to fix broken-hearts”; CreatiVets, supporting veterans suffering from PTSD; Yeshiva Academy, providing value-based education; and now XPRIZE Healthspan to drive healthier again for all. To learn more go to www.yieldofdreams.live. 

SeneGence, with over 25 years of experience in the health and beauty sector, is a valued member of the XPRIZE Innovation Board. The company is renowned for its expertise in anti-aging skincare and its development of long-lasting beauty products. SeneGence's unwavering commitment to research and development shines through its pioneering work in fields such as microbiome science, peptides, and stem cell research. This dedication aligns seamlessly with the goal of enhancing overall well-being and underscores their commitment to promoting beautiful, healthy skin. As investors in technologies that foster lasting beauty and anti-aging solutions, SeneGence continues to make significant contributions to the field. 

Sergey Young is a longevity investor and visionary with a mission to extend healthy lifespans of at least one billion people and make longevity more affordable and accessible to everyone. Following 20 years of investment expertise managing PE & VC funds, Sergey founded Longevity Vision Fund (LVF) in 2019 to invest in leading biotech companies targeting the underlying causes of aging.

LVF has grown its portfolio to 18 companies across gene therapies and editing, AI-enabled drug discovery, and early-stage diagnostics. LVF was honored as a World Changing Idea in Impact Investing by Fast Company in 2021 and 2022, along with leading global impact investing funds.

Sergey is on the Board of Directors of the American Federation of Aging Research (AFAR), Innovation Board Member at XPRIZE, and one of the co-creators of Healthspan XPRIZE global competition designed to reverse aging. Sergey is also transforming the world, one workplace at a time, with his initiative Longevity@Work – the first non-profit corporate longevity program of its kind.

As the author of the bestselling book ‘The Science and Technology of Growing Young’, Sergey has also been featured as a top longevity expert and contributor on CNN, Fox News, and Forbes.